Terms: = Lymphoma AND BCL11A, BCL11A-L, 53335, ENSG00000119866, FLJ34997, CTIP1, BCL11A-S, BCL11A-XL, KIAA1809, Q9H165, EVI9, FLJ10173 AND Prognosis
5 results:
1. Expression of bcl11a in chronic lymphocytic leukaemia.
Tosic N; Ugrin M; Marjanovic I; Kostic T; Vukovic V; Tomic K; Otasevic V; Antic D; Mihaljevic B; Pavlovic S; Karan-Djurasevic T
Int J Lab Hematol; 2023 Feb; 45(1):64-71. PubMed ID: 36120992
[TBL] [Abstract] [Full Text] [Related]
2.
Jin Q; Chen Y; Du S; Xu D; Yue J; Cai L; Yuan X
Curr Cancer Drug Targets; 2022; 22(11):919-930. PubMed ID: 35909289
[TBL] [Abstract] [Full Text] [Related]
3. miR‑574‑5p attenuates proliferation, migration and EMT in triple‑negative breast cancer cells by targeting bcl11a and SOX2 to inhibit the SKIL/TAZ/CTGF axis.
Zhang KJ; Hu Y; Luo N; Li X; Chen FY; Yuan JQ; Guo L
Int J Oncol; 2020 May; 56(5):1240-1251. PubMed ID: 32319565
[TBL] [Abstract] [Full Text] [Related]
4. [Preliminary study of gene expression profile associated with risk classification of childhood patients with acute lymphoblastic leukemia].
Wang JL; Chai YH; Ji ZH; Shao XJ; Huang YP
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):29-33. PubMed ID: 21429398
[TBL] [Abstract] [Full Text] [Related]
5. Primary mediastinal (thymic) large B-cell lymphoma: a short review with brief discussion of mediastinal gray zone lymphoma.
Hutchinson CB; Wang E
Arch Pathol Lab Med; 2011 Mar; 135(3):394-8. PubMed ID: 21366467
[TBL] [Abstract] [Full Text] [Related]
